INTRAVENOUS IMMUNOGLOBULIN TREATMENT INCREASES REGULATORY T CELLS IN HEART RECIPIENTS AFTER ANTI-IL2-RECEPTOR INDUCTION THERAPY

被引：0
|
作者：
Sarmiento, E. [1 ]
Lanio, N. [2 ]
Gallego, A. [1 ]
Palomo, J. [1 ]
Fernandez-Yanez, J. [1 ]
Fernandez-Cruz, E. [1 ]
Carbone, J. [1 ]
机构：
[1] Hosp Gen Gregorio Maranon, Madrid, Spain
[2] Hosp Univ Son Espases, Palma De Mallorca, Spain
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [41] Anti-IL-2 Receptor Antibodies versus Anti-Thymocyte Globulin for Induction Therapy in Kidney Transplantation
    Mandelbrot, Didier
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (06): : 1170 - 1171
  • [42] Altered balance between effector T cells and FOXP3+HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients
    Tang, Qizhi
    Leung, Joey
    Melli, Kristin
    Lay, Kimberly
    Chuu, Emmeline L.
    Liu, Weihong
    Bluestone, Jeffrey A.
    Kang, Sang-Mo
    Peddi, V. Ram
    Vincenti, Flavio
    TRANSPLANT INTERNATIONAL, 2012, 25 (12) : 1257 - 1267
  • [43] Anti-IL-2 receptor BT563 versus placebo: A randomized trial for induction therapy after liver transplantation
    Glanemann, M
    Langrehr, JM
    Raakow, R
    Guckelberger, O
    Lohmann, R
    Klupp, J
    Lobeck, H
    Schlag, H
    Keck, H
    Bechstein, WO
    Settmacher, U
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2159 - 2160
  • [44] Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells
    Netea, MG
    Sutmuller, R
    Hermann, C
    Van der Graaf, CAA
    Van der Meer, JWM
    van Krieken, JH
    Hartung, T
    Adema, G
    Kullberg, BJ
    JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3712 - 3718
  • [45] Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand Fc-specific regulatory T cells
    Hsieh, Li-En
    Song, Jaeyoon
    Tremoulet, Adriana H.
    Burns, Jane C.
    Franco, Alessandra
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 208 (03): : 361 - 371
  • [46] Anti-TNF antibody therapy in patients with rheumatoid arthritis, but not TNF receptor blockade, induces IL-17 suppressing regulatory T cells
    McGovern, J.
    Notley, C. A.
    Nguyen, X. D.
    Mauri, C.
    Isenberg, D. A.
    Ehrenstein, M. R.
    IMMUNOLOGY, 2010, 131 : 103 - 103
  • [47] Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
    Nellan, Anandani
    Rota, Christopher
    Majzner, Robbie
    Lester-McCully, Cynthia M.
    Griesinger, Andrea M.
    Levy, Jean M. Mulcahy
    Foreman, Nicholas K.
    Warren, Katherine E.
    Lee, Daniel W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [48] Oral corticosteroid sparing effects of anti-IL5/anti-IL5 receptor treatment after 2 years of treatment
    Bjerrum, Anne Sofie
    Skjold, Tina
    Schmid, Johannes Martin
    RESPIRATORY MEDICINE, 2021, 176
  • [49] The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients
    Sewgobind, Varsha D. K. D.
    Kho, Marcia M. L.
    van der Laan, Luc J. W.
    Hendrikx, Thijs K.
    van Dam, Thea
    Tilanus, Hugo W.
    IJzermans, Jan N. M.
    Weimar, Willem
    Baan, Carla C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (05) : 1635 - 1644
  • [50] Chimeric cytokine receptor provides IL-2 signaling for engineered regulatory T cell therapy
    Cortez, Jessica T.
    Ly, Han
    Trotta, Eleonora
    Matthaei, James F.
    Kegler, Peter
    Phong, Brian
    Fiebiger, Benjamin M.
    Torres, Josue
    Chase, Jack
    Mileur, Trevor
    Beilke, Joshua N.
    Bluestone, Jeffrey A.
    Ramsdell, Fred
    McKenzie, Brent S.
    Van Gool, Frederic
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
12345